Physician profile
Brett Wanamaker
NPI 1780953471
$24,783.93
in general payments reported to CMS, 2019-2025
14 companies · $8,103 in 2025
The $8,103 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,257 · 2020: $2,322 · 2021: $238 · 2022: $889 · 2023: $2,636 · 2024: $4,338 · 2025: $8,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,702 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,625 · Travel and Lodging: $3,730 · Honoraria: $20.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,701.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,625.00 |
| Travel and Lodging | $3,729.52 |
| Honoraria | $20.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,947.58 | 2019-2025 | General - Vascular Access, General - Therapies, Avvigo Guidance System |
| Medtronic Vascular, INC. | $6,402.79 | 2019-2020 | |
| Medtronic, INC. | $2,649.63 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Asahi Intecc USA, INC. | $1,621.77 | 2023-2025 | Peripheral Vascular, Asahi Coronary Wires, Asahi Ptca Guide Wire |
| Philips North America LLC | $1,415.57 | 2021-2024 | (Bq9) Coronary Ivus, (6574) Coronary Other, (P84) Igt Devices Systems |
| Asahi Intecc Co., Ltd. | $630.34 | 2023-2024 | Peripheral Vascular |
| Teleflex LLC | $395.32 | 2023-2025 | Guideliner, Manta, Turnpike |
| Abiomed | $273.75 | 2024-2025 | Impella |
| Reflow Medical INC | $154.60 | 2024 | |
| Siemens Medical Solutions USA, INC. | $148.79 | 2022 | |
| Biotronik INC. | $80.86 | 2022 | |
| Acist Medical Systems, INC. | $54.42 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.51 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Wanamaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.